市場調査レポート

商品コード

1320076

乾癬治療薬市場：療法クラス、治療タイプ、作用機序、投与経路、流通チャネル、用途別-2023～2030年の世界予測

Psoriasis Drugs Market by Therapeutic Class, Type of Treatment, Mechanism of Action, Route of Administration, Distribution Channel, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: 2023年06月12日 | 発行: 360iResearch

| ページ情報: 英文 192 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF, Excel & Online Access - 1 Year (Single User License)

USD 4,749 744,453円

レポートPDF及びExcelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Up to 5 User License)

USD 5,749 901,213円

レポートPDF及びExcelを5名まで共有ご利用頂けるライセンスです。ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Site License)

USD 6,749 1,057,973円

レポートPDF及びExcelを同一事業所（所在地）内のすべての方でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Enterprise User License)

USD 8,749 1,371,493円

レポートPDF及びExcelを同一企業の全世界の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

乾癬治療薬の世界市場は、2023年にCAGR 12.05%で96億7,453万米ドルが予測され、2030年には214億8,270万米ドルに達するという驚異的な成長を遂げると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の乾癬治療薬市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.乾癬治療薬の世界市場規模および予測は？

2.予測期間中、世界の乾癬治療薬市場を形成するCOVID-19の阻害要因と影響は？

3.乾癬治療薬の世界市場において予測期間中に投資すべき製品/セグメント/用途/分野は？

4.乾癬治療薬の世界市場における競争戦略は？

5.乾癬治療薬の世界市場における技術動向と規制の枠組みは？

6.乾癬治療薬の世界市場における主要ベンダーの市場シェアは？

7.乾癬治療薬の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

市場力学
- 促進要因
  - 乾癬の蔓延
  - 老人人口の増加と尋常性乾癬および乾癬性関節炎の有病率の増加
  - 乾癬治療薬の承認プロセスが簡単
- 抑制要因
  - 高額な治療費
- 機会
  - 乾癬の研究とパイプライン医薬品の増加
- 課題
  - 薬の副作用
市場動向
COVID-19の累積的な影響
ロシア・ウクライナ紛争の累積的影響
高インフレの累積的影響
ポーターのファイブフォース分析
バリューチェーンとクリティカルパス分析
規制の枠組み
顧客のカスタマイズ

第6章乾癬治療薬市場：療法クラス別

イントロダクション
インターロイキン阻害剤
腫瘍壊死因子阻害剤

第7章乾癬治療薬市場：治療タイプ別

イントロダクション
生物学的製剤
全身性療法
熱帯療法

第8章乾癬治療薬市場：作用機序別

イントロダクション
インターロイキン阻害剤
PDE4阻害剤
TNFα阻害剤

第9章乾癬治療薬市場：投与経路別

イントロダクション
経口
非経口
局所

第10章乾癬治療薬市場：流通チャネル別

イントロダクション
病院薬局
オンライン薬局
小売薬局

第11章乾癬治療薬市場：用途別

イントロダクション
関節炎
赤皮症
滴状
間質性
爪姓
プラーク
膿疱性

第12章南北アメリカの乾癬治療薬市場

イントロダクション
アルゼンチン
ブラジル
カナダ
メキシコ
米国

第13章アジア太平洋地域の乾癬治療薬市場

イントロダクション
オーストラリア
中国
インド
インドネシア
日本
マレーシア
フィリピン
シンガポール
韓国
台湾
タイ
ベトナム

第14章欧州・中東・アフリカの乾癬治療薬市場

イントロダクション
デンマーク
エジプト
フィンランド
フランス
ドイツ
イスラエル
イタリア
オランダ
ナイジェリア
ノルウェー
ポーランド
カタール
ロシア
サウジアラビア
南アフリカ
スペイン
スウェーデン
スイス
トルコ
アラブ首長国連邦
英国

第15章競合情勢

FPNVポジショニングマトリクス
市場シェア分析：主要企業別
競合シナリオ分析：主要企業別

第16章掲載企業一覧

第17章付録

ディスカッションガイド
ライセンスと価格について

図表

LIST OF FIGURES

FIGURE 1. PSORIASIS DRUGS MARKET RESEARCH PROCESS
FIGURE 2. PSORIASIS DRUGS MARKET SIZE, 2022 VS 2030
FIGURE 3. PSORIASIS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2022 VS 2030 (%)
FIGURE 5. PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2022 VS 2030 (%)
FIGURE 6. PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2022 VS 2030 (%)
FIGURE 7. PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
FIGURE 8. PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
FIGURE 9. PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 10. PSORIASIS DRUGS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 11. PSORIASIS DRUGS MARKET DYNAMICS
FIGURE 12. PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 18. AMERICAS PSORIASIS DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES PSORIASIS DRUGS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC PSORIASIS DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PSORIASIS DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 22. PSORIASIS DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 23. PSORIASIS DRUGS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

TABLE 1. PSORIASIS DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. PSORIASIS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 5. PSORIASIS DRUGS MARKET SIZE, BY INTERLEUKIN INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 6. PSORIASIS DRUGS MARKET SIZE, BY TUMOR NECROSIS FACTOR INHIBITOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 8. PSORIASIS DRUGS MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. PSORIASIS DRUGS MARKET SIZE, BY SMALL MOLECULE SYSTEMIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PSORIASIS DRUGS MARKET SIZE, BY TROPICAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 12. PSORIASIS DRUGS MARKET SIZE, BY INTERLEUKIN INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. PSORIASIS DRUGS MARKET SIZE, BY PDE4 INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. PSORIASIS DRUGS MARKET SIZE, BY TNF ALPHA INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 16. PSORIASIS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. PSORIASIS DRUGS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. PSORIASIS DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 20. PSORIASIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. PSORIASIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. PSORIASIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. PSORIASIS DRUGS MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. PSORIASIS DRUGS MARKET SIZE, BY ERYTHRODERMIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. PSORIASIS DRUGS MARKET SIZE, BY GUTTATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. PSORIASIS DRUGS MARKET SIZE, BY INTERTRIGINOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. PSORIASIS DRUGS MARKET SIZE, BY NAIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. PSORIASIS DRUGS MARKET SIZE, BY PLAQUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. PSORIASIS DRUGS MARKET SIZE, BY PUSTULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS PSORIASIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. CANADA PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 51. CANADA PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 52. CANADA PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 53. CANADA PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 54. CANADA PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. CANADA PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. MEXICO PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 57. MEXICO PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 58. MEXICO PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 59. MEXICO PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 60. MEXICO PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. MEXICO PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES PSORIASIS DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC PSORIASIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. AUSTRALIA PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. CHINA PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 83. CHINA PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 84. CHINA PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 85. CHINA PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 86. CHINA PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. CHINA PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. INDIA PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 89. INDIA PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 90. INDIA PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 91. INDIA PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 92. INDIA PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. INDIA PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. INDONESIA PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. JAPAN PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 101. JAPAN PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 102. JAPAN PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 103. JAPAN PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 104. JAPAN PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. JAPAN PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. MALAYSIA PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. PHILIPPINES PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. SINGAPORE PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. SOUTH KOREA PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. TAIWAN PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. THAILAND PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 137. THAILAND PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 138. THAILAND PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 139. THAILAND PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 140. THAILAND PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. THAILAND PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA PSORIASIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. DENMARK PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 156. DENMARK PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 157. DENMARK PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 158. DENMARK PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 159. DENMARK PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. DENMARK PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. EGYPT PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 162. EGYPT PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 163. EGYPT PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 164. EGYPT PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 165. EGYPT PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. EGYPT PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. FINLAND PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 168. FINLAND PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 169. FINLAND PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 170. FINLAND PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 171. FINLAND PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. FINLAND PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. FRANCE PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 174. FRANCE PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 175. FRANCE PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 176. FRANCE PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 177. FRANCE PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. FRANCE PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. GERMANY PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 180. GERMANY PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 181. GERMANY PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 182. GERMANY PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 183. GERMANY PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. GERMANY PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. ISRAEL PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. ITALY PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 192. ITALY PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 193. ITALY PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 194. ITALY PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 195. ITALY PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 196. ITALY PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. NORWAY PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 210. NORWAY PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 211. NORWAY PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 212. NORWAY PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 213. NORWAY PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. NORWAY PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. POLAND PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 216. POLAND PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 217. POLAND PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 218. POLAND PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 219. POLAND PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. POLAND PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. QATAR PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 222. QATAR PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 223. QATAR PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 224. QATAR PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 225. QATAR PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. QATAR PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. SPAIN PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 246. SPAIN PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 247. SPAIN PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 248. SPAIN PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 249. SPAIN PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 250. SPAIN PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. TURKEY PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 264. TURKEY PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 265. TURKEY PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 266. TURKEY PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 267. TURKEY PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 268. TURKEY PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM PSORIASIS DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM PSORIASIS DRUGS MARKET SIZE, BY TYPE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM PSORIASIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM PSORIASIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM PSORIASIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 280. UNITED KINGDOM PSORIASIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. PSORIASIS DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 282. PSORIASIS DRUGS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 283. PSORIASIS DRUGS MARKET LICENSE & PRICING

Product Code: MRR-434CCDA051BC

The Global Psoriasis Drugs Market is forecasted to grow significantly, with a projected USD 9,674.53 million in 2023 at a CAGR of 12.05% and expected to reach a staggering USD 21,482.70 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Psoriasis Drugs Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Psoriasis Drugs Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Therapeutic Class, market is studied across Interleukin Inhibitors and Tumor Necrosis Factor Inhibitor. The Interleukin Inhibitors is projected to witness significant market share during forecast period.

Based on Type of Treatment, market is studied across Biologic Drugs, Small Molecule Systemic Drugs, and Tropical Therapies. The Tropical Therapies is projected to witness significant market share during forecast period.

Based on Mechanism of Action, market is studied across Interleukin Inhibitors, PDE4 Inhibitors, and TNF Alpha Inhibitors. The Interleukin Inhibitors is projected to witness significant market share during forecast period.

Based on Route of Administration, market is studied across Oral, Parenteral, and Topical. The Topical is projected to witness significant market share during forecast period.

Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies. The Retail Pharmacies is projected to witness significant market share during forecast period.

Based on Application, market is studied across Arthritis, Erythrodermic, Guttate, Intertriginous, Nail, Plaque, and Pustular. The Intertriginous is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Psoriasis Drugs Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Psoriasis Drugs Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Psoriasis Drugs Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Psoriasis Drugs Market?

4. What is the competitive strategic window for opportunities in the Global Psoriasis Drugs Market?

5. What are the technology trends and regulatory frameworks in the Global Psoriasis Drugs Market?

6. What is the market share of the leading vendors in the Global Psoriasis Drugs Market?

7. What modes and strategic moves are considered suitable for entering the Global Psoriasis Drugs Market?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Psoriasis Drugs Market, by Therapeutic Class, 2022 vs 2030
4.3. Psoriasis Drugs Market, by Type of Treatment, 2022 vs 2030
4.4. Psoriasis Drugs Market, by Mechanism of Action, 2022 vs 2030
4.5. Psoriasis Drugs Market, by Route of Administration, 2022 vs 2030
4.6. Psoriasis Drugs Market, by Distribution Channel, 2022 vs 2030
4.7. Psoriasis Drugs Market, by Application, 2022 vs 2030
4.8. Psoriasis Drugs Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing prevalence of psoriasis
  - 5.1.1.2. Rising geriatric population coupled with growing prevalence of plaque psoriasis and psoriatic arthritis
  - 5.1.1.3. Ease of process of approval of psoriasis drugs
- 5.1.2. Restraints
  - 5.1.2.1. High cost of treatment
- 5.1.3. Opportunities
  - 5.1.3.1. Increase in psoriasis research and pipeline drugs
- 5.1.4. Challenges
  - 5.1.4.1. Side effects of the medication
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Psoriasis Drugs Market, by Therapeutic Class

6.1. Introduction
6.2. Interleukin Inhibitors
6.3. Tumor Necrosis Factor Inhibitor

7. Psoriasis Drugs Market, by Type of Treatment

7.1. Introduction
7.2. Biologic Drugs
7.3. Small Molecule Systemic Drugs
7.4. Tropical Therapies

8. Psoriasis Drugs Market, by Mechanism of Action

8.1. Introduction
8.2. Interleukin Inhibitors
8.3. PDE4 Inhibitors
8.4. TNF Alpha Inhibitors

9. Psoriasis Drugs Market, by Route of Administration

9.1. Introduction
9.2. Oral
9.3. Parenteral
9.4. Topical

10. Psoriasis Drugs Market, by Distribution Channel

10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies

11. Psoriasis Drugs Market, by Application

11.1. Introduction
11.2. Arthritis
11.3. Erythrodermic
11.4. Guttate
11.5. Intertriginous
11.6. Nail
11.7. Plaque
11.8. Pustular

12. Americas Psoriasis Drugs Market

12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States

13. Asia-Pacific Psoriasis Drugs Market

13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam

14. Europe, Middle East & Africa Psoriasis Drugs Market

14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom

乾癬治療薬市場：療法クラス、治療タイプ、作用機序、投与経路、流通チャネル、用途別-2023～2030年の世界予測

Psoriasis Drugs Market by Therapeutic Class, Type of Treatment, Mechanism of Action, Route of Administration, Distribution Channel, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

FPNVポジショニング・マトリックス

市場シェア分析

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

第6章 乾癬治療薬市場：療法クラス別

第7章 乾癬治療薬市場：治療タイプ別

第8章 乾癬治療薬市場：作用機序別

第9章 乾癬治療薬市場：投与経路別

第10章 乾癬治療薬市場：流通チャネル別

第11章 乾癬治療薬市場：用途別

第12章 南北アメリカの乾癬治療薬市場

第13章 アジア太平洋地域の乾癬治療薬市場

第14章 欧州・中東・アフリカの乾癬治療薬市場

第15章 競合情勢

第16章 掲載企業一覧

第17章 付録